Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXU4UN
|
||||
Drug Name |
(R)-2-Bromo-N-[5-(2-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide
|
||||
Synonyms |
CHEMBL2092866
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H17BrFN3O2
|
||||
Canonical SMILES |
CN1C(=O)[C@H](NC(=O)c2ccccc2Br)N=C(c3ccccc3F)c4ccccc14
|
||||
InChI |
InChI=1S/C23H17BrFN3O2/c1-28-19-13-7-4-10-16(19)20(15-9-3-6-12-18(15)25)26-21(23(28)30)27-22(29)14-8-2-5-11-17(14)24/h2-13,21H,1H3,(H,27,29)/t21-/m0/s1
|
||||
InChIKey |
QOBSCDLYMYAIFX-NRFANRHFSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.